Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension.
Piotr ToustyMagda Fraszczyk-ToustyAnna GolaraAdrianna ZahorowskaMichał SławińskiSylwia DzidekHanna Jasiak-JóźwikMagda Nawceniak-BalczerskaAgnieszka KordekEwa KwiatkowskaAneta Cymbaluk-PłoskaAndrzej TorbéSebastian KwiatkowskiPublished in: Journal of clinical medicine (2023)
The first-trimester screening test for PE and FGR is a necessary and effective tool in identifying high-risk pregnancies. ASA prophylaxis among high-risk patients may have the most beneficial effect. Furthermore, this screening tool may significantly reduce the incidence of early-onset PE (eo-PE).
Keyphrases
- early onset
- late onset
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- blood pressure
- polycystic ovary syndrome
- peritoneal dialysis
- risk factors
- prognostic factors
- preterm birth
- patient reported outcomes
- adipose tissue
- insulin resistance
- pregnant women
- skeletal muscle
- gestational age
- drug induced
- cervical cancer screening
- arterial hypertension